Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-9090 in Relapsed or Refractory Small Cell Lung Cancer
NCT01173523Phase 2Completed
- Start
- Jul 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in small cell lung cancer (SCLC). Started Jul 2010; status: completed.
02
Drugs
ganetespib
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT01173523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173523.